Sorrento Therapeutics Inc (SRNE)

[dia76ca]

Sorrento, along with many small biotechs has two weaknesses. They are treated poorly by the FDA, and they do a poor job of communicating with their retail shareholders.
I totally support their 8 month old announced intention to partner with a Big Pharma around their amazingly effective drug ABIVERTINIB. This partnership would benefit the finances. It would be worth multi-billions in up-front payments, milestones and royalties!
This partnership would finance the entire portfolio and could also address the two weaknesses that I referred to.
Big Pharma obviously have more influence with the FDA.
But I would also like them to have a seat on the Sorrento BOD and I would expect them to bring many professional investor relations practices to Sorrento.
There should be good news about ABIVERTINIB very soon. And SEMDEXA and RTX have great potential. But don't write off the the Covid portfolio. Covid will be with us for many years and COVISTIX, COVI-MSC, COVI-Shield and Mpro could have a long term benefits for many patients.